Nodus Oncology

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

Enodia Therapeutics

This biotechnology company develops small-molecule therapies for targeted protein degradation to treat inflammatory, autoimmune and oncological diseases in patients.

Accent Therapeutics

This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.

Ikena Oncology

This clinical-stage biotechnology company develops targeted oncology therapies and small molecule modulators for patients with biomarker-driven cancers and unmet medical needs.

Synnovation Therapeutics

This company develops small molecule precision medicines and targeted therapies to treat cancer patients.

Ribon Therapeutics

This biotechnology company develops small molecule inhibitors targeting stress support pathways for patients with cancer and inflammatory diseases.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

Tipping Point Biosciences

This biotechnology company develops a drug discovery platform and small molecule therapies targeting dysfunctional DNA packaging for patients with cancer and neurodegenerative diseases.